BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 2, 2003
View Archived Issues
Enrollment completed in phase II trial of SRP-299 for asthma
Read More
Thai phase IIa trial of DB-289 for malaria opens enrollment
Read More
Acapodene reduces high-grade prostate intraepithelial neoplasia in phase II study
Read More
Lexicon Genetics discover new target for cognitive disorders
Read More
Positive Japanese phase III data for Zadaxin in hepatitis B
Read More
Cypress Bioscience prepares for milnacipran trial in IBS
Read More
Phase I results for NBI-42902
Read More
Schering acquires license to Philogen's antibody-based therapeutic fusion protein
Read More
Manufacturing begins in preparation for EradicAide trial
Read More
Oxazole-based inducers of BDNF production and their use in diabetic neuropathy
Read More
New aciclovir prodrugs and their use in ocular viral infections
Read More
Roche researchers describe the preparation and use of novel cathepsin K inhibitors
Read More
New CRF antagonists in early development at Roche
Read More
Novel glucagon antagonists in Novo Nordisk development pipeline
Read More
Novartis patents new mGluR5 antagonists for anxiety, pain, etc.
Read More
Metabolic glutamate mGluR5 antagonists covered by Merck patent
Read More
New thrombin inhibitors prepared and tested by U. of Ljubljana and LEK researchers
Read More
Inhibition of alpha4beta1 as a new approach to multiple sclerosis
Read More
In vitro and in vivo profile of new orally active histamine H3 antagonist
Read More
CPMP hands down positive opinion for Avandamet
Read More
Clenoliximab enhances the efficacy of methotrexate in active rheumatoid arthritis
Read More
Comparison of the efficacy and safety profiles of etoricoxib and naproxen in rheumatoid arthritis
Read More
Inspire files first NDA for ocular therapy partnered with Allergan
Read More
Phase III ARISE trial of AGI-1067 opens enrollment
Read More
ABthrax cleared to enter clinical testing
Read More
Bexxar approved by FDA
Read More
Beneficial effects of pregabalin in healthy volunteers and patients with fibromyalgia
Read More